Patent 11780933 was granted and assigned to Hummingbird Bioscience on October, 2023 by the United States Patent and Trademark Office.
HER3 antigen-binding molecules are disclosed. Also disclosed are nucleic acids and expression vectors encoding, compositions comprising, and methods using, the HER3 antigen-binding molecules.